Abstract
Percutaneous microwave coagulation therapy (PMCT) was performed on 31 patients with hepatocellular carcinoma (HCC) smaller than 3 cm in diameter (average 2 cm). According to Child classification, 14 patients were in the Child grade A, 15 in the Child grade B, and 2 in the Child grade C. The 1-, 2- year survival rates were 100%, 88%. Local recurrences in the advanced nodules were more often observed than in the early nodules. Major complications of the treatment were peritoneal bleeding in two patients and subcapsular liver hemorrhage in one patient. PMCT seems to be a valuable percutaneous local treatment for small HCC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
